S'abonner

Post-surgical recurrence of Crohn's disease: Situational analysis and future prospects - 10/10/21

Doi : 10.1016/j.jviscsurg.2021.03.012 
C. Valibouze a, b, , P. Desreumaux b, c, P. Zerbib a, b
a Department of Digestive Surgery and Transplantation, Lille Nord de France University, Claude Huriez Hospital, University Hospital of Lille, Rue Michel Polonovski, 59037 Lille, France 
b University of Lille, INSERM, U1286 - Infinite - Institute for Translational Research in Inflammation, Lille, France 
c Hepato-Gastroenterology Department, Lille Nord de France University, Claude Huriez Hospital, University Hospital of Lille, 59037 Lille, France 

Corresponding author at: Department of Digestive Surgery and Transplantation, Lille Nord de France University, Hôpital Claude-Huriez, CHU de Lille, Rue Michel Polonovski, 59037 Lille, France.Department of Digestive Surgery and Transplantation, Lille Nord de France University, Hôpital Claude-Huriez, CHU de LilleRue Michel PolonovskiLille59037France

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

pages 10
Iconographies 2
Vidéos 0
Autres 0

Highlights

30–50% of patients with Crohn's disease will require surgery during their lifetime in order to resolve obstructive symptoms in the more or less long term. However, almost all patients develop endoscopic recurrence post-operatively; its detection is essential since it precedes the development of clinical recurrence that may require surgery. Eventually, 15–20% of resected patients will require a new intestinal resection.
Several risk factors have been implicated in post-operative recurrence: smoking, repeated and/or extensive resections (>50cm), anoperineal involvement, myenteric plexitis, epithelioid granulomas and lack of post-operative prophylactic treatment. The penetrating phenotype of Crohn's disease, classically recognized as promoting post-operative recurrence, has more recently been identified as a protective factor against recurrence.
Currently, the prevention of recurrence requires the cessation of smoking in all cases and the prescription of anti-TNF to patients at high risk of recurrence (at least two risk factors). However, the effectiveness of anti-TNF agents is limited and diminishes over time.
The consensus of ECCO (European Crohn's and Colitis Organization) favors a lateral stapled anastomosis for ileocecal resection and considers stricturoplasty as a valid alternative to resection for short or long strictures of the small intestine except for perforating disease where only resections are possible. Long stricturoplasty techniques for extensive strictures have provided encouraging results with regard to endoscopic healing and long-term surgical recurrence.
The side-to-side Kono anastomosis and intestinal resections that include extensive mesenteric resection have shown promising results leading to decreased endoscopic, clinical and surgical recurrence. These new techniques could thus limit the need for post-operative prescription of immunomodulators in patients considered to be at high risk of recurrence.

Le texte complet de cet article est disponible en PDF.

Summary

Surgery retains a major role in the treatment of Crohn's disease, and the prevention of post-operative recurrence is an essential issue. In fact, despite the increasing use of biotherapies, almost all of the patients who undergo surgery will present with a recurrence, initially endoscopic and then clinical, eventually leading to a second intervention in 15 to 20% of cases. Certain risk factors for recurrence such as smoking, repeated and/or extensive resections, anoperineal involvement, myenteric plexitis, epithelioid granulomas, penetrating disease behaviour and lack of post-operative prophylactic treatment have been well established. Currently, measures to prevent post-operative recurrence are based mainly on smoking cessation in all patients and the prescription of anti-TNFα medications for patients with a high risk of recurrence (at least two risk factors for recurrence). However, new surgical techniques have recently been described which could modify post-operative prevention strategies. Kono's lateral anti-mesenteric anastomosis could significantly reduce clinical and endoscopic recurrence compared to conventional anastomosis techniques. Long latero-lateral isoperistaltic stricturoplasties have been shown to be feasible and are associated with a low rate of long-term symptomatic recurrence requiring surgery. In a preliminary series, intestinal resections with extensive mesenteric resection reduced the rate of recurrence in comparison with patients operated on conventionally (3% vs. 40% at five years). If the results of these new surgical techniques are confirmed, the indications for post-operative immunomodulatory treatments could be downgraded in patients currently considered to be at high risk of recurrence.

Le texte complet de cet article est disponible en PDF.

Keywords : Crohn's disease, Recurrence, Ileocecal resection, Anastomosis


Plan


© 2021  Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 158 - N° 5

P. 401-410 - octobre 2021 Retour au numéro
Article précédent Article précédent
  • History of first transplantations: Nothing is ever written. Part II
  • E. Martinod, O. Soubrane, E. van Glabeke, S. Drouin, B. Barrou, A. Zarzavadjian Le Bihan, C. Trésallet
| Article suivant Article suivant
  • Management of abdominal compartment syndrome in acute pancreatitis
  • M. Siebert, A. Le Fouler, N. Sitbon, J. Cohen, J. Abba, E. Poupardin

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.